For example, many breast cancer patients received both estrogen receptor (ER) antagonist and aromatase inhibitor therapy, and many patients received more than one genotoxic therapy (e.g., anthracyclines, DNA alkylating agent, DNA synthesis inhibitor). The gene discussed is ESR1; the disease is breast cancer.